| Date | Title | Description | Source |
| 26.03.2024 | Nouscom secures additional funding from Angelini Ventures |
Based in Basel, Nouscom is a clinical stage immune-oncology company developing off-the-shelf and pe... | startuptic... |
| 21.03.2024 | Angelini Ventures invests into extended €75.8 million ($82 m... | - | globenewsw... |
| 21.12.2023 | INDACO VENTURE PARTNERS – NOUSCOM RAISES €67.5 MILLION ($72 ... | | indacosgr.... |
| 20.12.2023 | Fierce Biotech Fundraising Tracker '23: Carmot spinoff Kimia... | We've launched a new Fierce Biotech Fundraising Tracker for 2023 to track all the venture capital fl... | fiercebiot... |
| 14.11.2023 | Andera Partners co-leads a €67.5 million ($72 million) overs... | Andera Partners, a leading European private equity player, today announces that it is co-leading a €... | anderapart... |
| 14.11.2023 | Nouscom Raises €67.5m in Series C Financing | Nouscom, a Basel, Switzerland-based clinical stage immuno-oncology company, raised €67.5M in Series ... | finsmes.co... |
| 14.11.2023 | Nouscom Raises €67.5 million ($72 million) in Oversubscribed... | - | globenewsw... |
| 14.11.2023 | Nouscom raises CHF65 million in oversubscribed Series C fina... | | startuptic... |
| 09.01.2023 | Nouscom and MSD sign a clinical trial and supply agreement | | startuptic... |
| 21.11.2022 | Nouscom’s lead molecule enters Phase 2 clinical trials | | startuptic... |
| 29.06.2022 | New C-Suite leaders assume responsibility to boost startup g... | | startuptic... |
| 18.05.2022 | Successful collaboration between Nouscom and Janssen | | startuptic... |
| 22.09.2021 | Encouraging clinical results for Nouscom’s lead molecule | | startuptic... |
| 12.03.2021 | Green light for clinical trials of Nouscom's personalized ca... | | startuptic... |
| 12.03.2021 | Green light for clinical trials of Nouscom's personalized ca... | NOUS-PEV is a personalized vaccine designed for each patient based on the selection and prioritizati... | startuptic... |
| 30.12.2020 | New board members to accelerate growth | | startuptic... |
| 30.12.2020 | New board members to accelerate growth | Exnaton, an ETH spinoff providing a software platform (PowerQuartier) for energy communities, welcom... | startuptic... |
| 28.12.2020 | C-suite managers for Swiss startups | Clinerion provides its proprietary Patient Network Explorer that radically improves the efficiency a... | startuptic... |
| 28.12.2020 | C-suite managers for Swiss startups | | startuptic... |
| 13.06.2018 | New CEO and CMO for biotech startups | | startuptic... |
| 07.11.2017 | Term Sheet — Tuesday, November 7 | THE LITTLE PINK PILL
Good morning, Term Sheet readers.
Paid Content You can't secure what you can't ... | fortune.co... |
| 06.11.2017 | NOUSCOM RAISES €42 MILLION SERIES B FINANCING | - | 5amventure... |
| 06.11.2017 | Versant Ventures Joins 42M Euros Series B for NousCom | NousCom, an oncology company developing neoantigen based cancer vaccines based on its Exovax platfor... | citybizlis... |
| 06.11.2017 | 5AM Ventures Joins 42M Euros Series B for NousCom | NousCom, an oncology company developing neoantigen based cancer vaccines based on its Exovax platfor... | citybizlis... |
| 06.11.2017 | NousCom secures €42 Million in Series B Financing | | startuptic... |
| 06.11.2017 | NousCom Closes €42M Series B Funding Round | NousCom, a Basel, Switzerland–based oncology company, closed its €42m Series B funding round.
The ro... | finsmes.co... |
| 30.01.2017 | Startup di successo 2016, chi ha raccolto di più | L’universo delle startup italiane, cresce lentamente. Il Politecnico di Milano, inoltre, accerta com... | startup-ne... |
| 17.05.2016 | Nouscom Closes €12M in Series A Funding | Nouscom, a Basel, Switzerland and Rome, Italy-based biotech company, closed €12m in Series A funding... | finsmes.co... |
| 17.05.2016 | New company of former Okairos founders bags €12 million | | startuptic... |
| - | Nouscom | “Nouscom is a next-generation immunotherapy company developing genetic cancer vaccines and oncolytic... | fastfounde... |
